News from
Science, Economy
and the BIO.NRW network
News
BioEcho Life Sciences announces FDA listing of its EchoLUTION Viral RNA/DNA Kit for nucleic acid extraction
The EchoLUTION Viral RNA/DNA Kit is now available for the US diagnosis market to extract nucleic acids from viral particles with a unique single-centrifugation technology, reducing processing time for in vitro diagnostic ...
Report on the BIO.NRW MEDICA Forum 2023
Aspects of data-driven, integrative approaches for individually optimized medicine At this year’s BIO.NRW MEDICA Forum, the speakers gave presentations on a wide range of aspects related to data-driven, individually optimized medicine. Some ...
EFIB 2023: Industrial Biotechnology for a Sustainable and Resilient Global Europe
This year was BIO.NRW’s first time to have a stand at the European Forum For Industrial Biotechnology & The Bioeconomy (EFIB) in Rotterdam (Netherlands) on 24 and 25 October 2023. Together with ...
Report on the GMS Event 2023
On 8 and 9 November 2023, innovative enterprises and decision makers from all sectors met at “The Greener Manufacturing Show” in Cologne to discuss topics related to a sustainable and climate-smart industry ...
New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study
Press release from 20 November 2023 Priavoid GmbH and PRInnovation GmbH announce today that the European Medicines Agency (EMA) has granted approval to conduct a Phase II clinical trial for the drug ...
Pioneers from NRW – Hunting the pathogen with biosensors
In our series Pioneers from NRW, Gabriela Figueroa Miranda and Viviana Rincón Montes talk about their exciting work at Forschungszentrum Jülich. The postdocs and entrepreneurs talk about their academic careers, their stations ...
News archive
BioEcho Life Sciences announces FDA listing of its EchoLUTION Viral RNA/DNA Kit for nucleic acid extraction
The EchoLUTION Viral RNA/DNA Kit is now available for the US diagnosis market to extract nucleic acids from viral particles ...
Report on the BIO.NRW MEDICA Forum 2023
Aspects of data-driven, integrative approaches for individually optimized medicine At this year’s BIO.NRW MEDICA Forum, the speakers gave presentations on ...
EFIB 2023: Industrial Biotechnology for a Sustainable and Resilient Global Europe
This year was BIO.NRW’s first time to have a stand at the European Forum For Industrial Biotechnology & The Bioeconomy ...
Pioneers from NRW – Dr. Bert Klebl, Lead Discovery Center
“It’s a match: Tindering Academia with Pharma” Dr. Klebl is the initiator, as well as executive and scientific director ...
Christmas elves in action!
This year, the BIO.NRW team is particularly keen to continue its long-standing charity campaign for the Düsseldorfer food bank. Financed ...
How to expand to the U.S. – a retrospective
The event How to expand to the US took place on November 14 on the occasion of MEDICA in Düsseldorf ...
German Biotechnology Days 2023
The German Biotechnology Days (DBT) will be held in Wiesbaden on March 28 and 29. The event is considered the ...
Release of the new Spot on Biotechnology Science 2021/2022
At the end of 2021, we present the publication of the new edition of the brochure „Spot on Biotechnology Science“ ...
Updated Horizon Europe work program published
The European Commission published on 16th of December 2021 an updated Horizon Europe work program for 2021 - 2022 with ...
Premiere in Cologne: The Greener Manufacturing Show 2021
On 10 and 11 November, The Greener Manufacturing Show was held in Cologne for the very first time. The exhibition ...
Microalgae for Greater Sustainability
How can algae be used to enable a more sustainable economy? The BIO.NRW.eco team addressed this issue in the “Algae ...
Bioeconomy now with more visibility on our BIO.NRW homepage!
Definitions, backgrounds, specific funding tools and relevance for NR is discussed. The bioeconomy now has its own tab on the ...
New Bioeconomy Council convenes for its constituent meeting
The Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Food and Agriculture (BMEL) have appointed the ...
AiCuris receives approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany
The Compassionate Use Program (CUP) may provide access to pritelivir for use in immunocompromised patients that have acyclovir-resistant mucocutaneous herpes ...
EuropaBio Webinar: The European Commission’s Toolbox for Biotech SMEs & Start-Ups
The Webinare is part of a series by EuropaBio on "How does the EU support small – and medium sized ...
No posts found.
No posts found.
No posts found.